Stocktoria
Bon Natural Life Ltd BON
Nasdaq · stock · Medicinal Chemicals & Botanical Products · website · IPO 2021-06-24
Bon Natural Life Ltd financials (annual)
Bars are annual figures from 2020 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $18.7M | $23.8M | $29.5M | $29.9M | $25.5M | $18.2M |
| Gross profit | $3.9M | $7.1M | $8.8M | $9.4M | $7.1M | $5.2M |
| R&D expense | $754,193 | $1.6M | $298,469 | $424,558 | $249,050 | $205,359 |
| Operating income | -$1.6M | $1.9M | $5.9M | $6.6M | $5.4M | $3.5M |
| Interest expense | $366,180 | $303,325 | $238,224 | $446,884 | $417,266 | $329,102 |
| Income tax | $339,414 | $351,179 | $1.0M | $1.3M | $820,931 | $556,262 |
| Net income | -$2.0M | $398,172 | $4.6M | $6.2M | $4.6M | $3.0M |
| EPS (diluted) | $-0.72 | $4.14 | $124.92 | $7.43 | $0.68 | $0.58 |
| Operating cash flow | $141,115 | -$7.7M | $6.3M | -$187,121 | $4.1M | $2.6M |
| Free cash flow | $134,288 | -$7.7M | $6.3M | -$214,816 | $4.0M | $2.6M |
| Cash & equivalents | — | $80,466 | — | — | — | — |
| Inventory | $3.3M | $1.6M | $987,287 | $1.7M | $1.6M | $1.0M |
| Total assets | $85.2M | $61.8M | $46.6M | $37.3M | $36.4M | $25.2M |
| Total liabilities | $27.2M | $17.4M | $10.6M | $7.2M | $9.9M | $14.2M |
| Shareholders' equity | $58.0M | $44.3M | $36.0M | $30.1M | $26.5M | $11.0M |
Growth · year-over-year · Revenue CAGR 0.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue growth | -21.7% | -19.2% | -1.3% | +17.3% | +39.9% | — |
| Net income growth | -601.0% | -91.3% | -26.3% | +35.9% | +51.7% | — |
| EPS growth | -117.4% | -96.7% | +1581.3% | +992.6% | +17.2% | — |
| Free cash flow growth | — | -223.1% | — | -105.4% | +53.2% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-09-30. Facts plus Stocktoria's own computed scores — not investment advice.